Hypereosinophilic syndrome

Indian Journal of Pediatrics

Volumn 73, Issue 3, 2006, Pages 237-239

  Venkatesh, C ^a   Mahender, E ^a   Janani, S ^a,b   Malathi, S ^a   Vijayakumar, M ^a   Nammalwar, B R ^a  

^a KANCHI KAMAKOTI CHILDS TRUST HOSPITAL   (India)

^b Childs Trust Hospital   (India)

Author keywords

End organ damage; Eosinophilia

Indexed keywords

CEFALEXIN; DOXYCYCLINE; MEROPENEM; METHYLPREDNISOLONE; NETILMICIN; PREDNISOLONE; VANCOMYCIN; GLUCOCORTICOID;

ADOLESCENT; ARTICLE; BACTERIAL PNEUMONIA; BLOOD TRANSFUSION; BONE MARROW BIOPSY; CASE REPORT; CELL PROLIFERATION; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; EOSINOPHIL; FOLLOW UP; HUMAN; HUMAN TISSUE; HYPEREOSINOPHILIC SYNDROME; LABORATORY TEST; LEUKOCYTE; MALE; MULTIPLE ORGAN FAILURE; PHYSICAL EXAMINATION; RADIODIAGNOSIS; SPUTUM CULTURE; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

ADOLESCENT; GLUCOCORTICOIDS; HUMANS; HYPEREOSINOPHILIC SYNDROME; MALE; PREDNISOLONE;

EID: 33746234881     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02825491     Document Type: Article

References (10)

1. Chusid MJ, Dale DC, West BC Wolff SM. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 1975; 54: 1-27.
2. Boxer LA. Hypereosinophilic syndrome. In Behrman RE, Kliegman RM, Jenson HB, eds. Nelson textbook of Pediatrics. 17th edn. Philadelphia; Saunders, 2004; 710.
3. Schooley RT, Flaum MA, Gralnick HR, Fauci AS. A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome II. Clinical manifestations. Blood 1981; 58 : 1021-1026.
4. Alfaham MA, Ferguson SD, Sihra B, Davies J. The idiopathic hypereosinophilic syndrome. Arch Dis Child 1987; 62 : 601-613.
5. Bain BJ, Eosinophilic leukemias and the idiopathic hypereosinophilic syndrome. Br J Haematol 1996; 95 : 2-9.
6. Roufosse F, Bartholome E, Schandene L, Goldman M, Cogan E.The idiopathic hypereosinophilic syndrome: Clinical presentation, pathogenesis and therapeutic strategies. Drugs Today (Barc) 1998; 34: 361-373.
7. Klion AD, Robyn J, Akin C, Noel P, Brown M, Law M, Metcalfe DD, Dunbar C, Nutman TB. Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with myeloproliferative variant of hypereosinophilic syndrome. Blood 2004; 103 : 473-478.
8. Klion AD, Law MA, Noel P, Kim YJ, Haverty TP, Nutman TB. Safety and efficacy of monoclonal anti interleukin 5 antibody SCH 55700 in the treatment of patients with hypereosinophilic syndrome. Blood 2004; 103 : 2939-2941.
9. Juvonen E, Volin L, Koponen A, Ruutu T. Allogeneic blood stem cell transplantation following non-myeloablative conditioning for hypereosinophilic syndrome. Bone Marrow Transplantation 2002; 29: 457-458.
10. Takeda S, Takazakura E, Fukui Y. Tubulointerstitial nephritis in a patient with eosinophilic fasciitis and IgA nephropathy. Nephron 1995; 69 : 314-317.